|
CN101622352A
|
|
The method and the application thereof of the conjugate of the toxin that selection and generation are modified, the toxin that contains modification
|
|
WO2008080218A1
|
|
Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
|
|
AU2007201753A1
|
|
Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent
|
|
AU2007200061A1
|
|
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
AU2004202331A1
|
|
Methods and Compositions for Treating Secondary Tissue Damage and Other Inflammatory Conditions and Disorders
|
|
US7157418B1
|
|
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
EP1098664A2
|
|
Conjugates for treating inflammatory disorders and associated tissue damage
|
